Healthcare & Life Sciences
OncoC4
United Stateswww.oncoc4.com/
OncoC4 is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About OncoC4
Based in the United States, OncoC4 is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
OncoC4 develops therapeutics targeting innate and adaptive immune checkpoints such as CTLA-4, PD-1/VEGF, Siglec, and CD24 to treat hard-to-treat cancers and Alzheimer's disease using modalities including monoclonal antibodies, bispecific antibodies, and antibody-drug conjugates.
Explore OncoC4's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.